Head-to-head · WeighScore
Peptivo vs Virta Health
The verdict
Peptivo takes it — 60.1/100 to 59.7/100, but only just.
Peptivo grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Peptivo is a 100% online GLP-1 weight-loss telehealth service offering compounded medication made in the USA at FDA-registered labs, with same-day provider visits and 24/7 messaging. Virta Health is close behind and may still be the better fit — see the factor split below.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Peptivo | Virta Health |
|---|---|---|
| WeighScore | 60.1/100 | 59.7/100 |
| Grade | C | C |
| Scorecard rank | #331 | #337 |
| Semaglutide | Not disclosed | Not disclosed |
| Tirzepatide | Not disclosed | Not disclosed |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Injection only | Yes |
Graded #331 · C
Strengths
- Low entry pricing — GLP-1 weight-loss plans starting at $169/mo, with free discreet shipping
- Same-day provider visits and 24/7 provider messaging; 100% online
- Compounded in the USA at FDA-registered labs; can also prescribe brand GLP-1 (Ozempic, Wegovy, Zepbound)
- FSA/HSA eligible with upfront pricing
Where it loses points
- GLP-1 products use generic names ('GLP-1 Daily Support', 'Weight Loss Boost') — semaglutide/tirzepatide not clearly broken out
- Compounding pharmacy/lab partner not named
- Limited published policies (privacy and terms only; no HIPAA notice or refund policy found)
- Not LegitScript-certified (no certification displayed)
Graded #337 · C
Strengths
- Offers a Responsible Prescribing track with optimized GLP-1 use
- Clinically monitored medication off-ramp toward nutrition therapy
- Nutrition-first model shown to rival GLP-1 weight loss (about 13% at 1 year)
- Provided at no cost to members through employers and health plans
- Strong evidence base for diabetes reversal and metabolic health
Where it loses points
- Primarily a nutrition program; GLP-1s are a secondary track
- Distributed via employers and health plans, no direct cash-pay
- Deliberately discourages GLP-1 use for most members
- GLP-1 access depends on the specific program the plan selects
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.